By Josh White
Date: Thursday 14 Aug 2025
(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.
By Josh White
Date: Monday 16 Jun 2025
(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.
By Benjamin Chiou
Date: Friday 11 Oct 2024
(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.
Currency | UK Pounds |
Share Price | 14.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 26.10p |
52 Week Low | 10.38p |
Volume | 635,099 |
Shares Issued | 258.78m |
Market Cap | £36.88m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:30 | 38,425 @ 14.50p |
15:54 | 38,425 @ 14.25p |
14:33 | 24,827 @ 14.23p |
14:31 | 35,620 @ 14.07p |
14:04 | 140,374 @ 14.24p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research